While CXCL12 is considered to act primarily as a proatherogenic chemokine, activation of the CXCL12/CXCR4/CXCR7 axis can in fact lead to both the progression and stabilization of atherosclerosis [26,27,28]. This evidence concerns the gene CXCL12 and atherosclerosis.